Skip to main content
    E

    Elanco Animal Health (ELAN)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NYSE

    $26.43
    -0.35 (-1.31%)

    Market Cap: $13.39B

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Elanco Animal Health (ELAN) P/E Ratio & Valuation History

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    Elanco Animal Health (ELAN) trades at 23.2x trailing earnings and 2.6x sales. Its P/E of 23.2x is above its 5-year median of 16.8x. Its forward P/E is 20.6x. The median P/E across 10 similar companies is 18.2x.

    Current Multiples

    Its forward P/E is below its trailing P/E, which implies earnings per share about 12.6% higher over the next year. Its free cash flow yield is 3.1%.

    MultipleValue
    P/E (trailing)23.2x
    Forward P/E20.6x
    Price to sales2.6x
    Price to book2.0x
    EV/EBITDA19.2x
    Price to FCF32.4x
    EV/FCF40.3x
    PEG8.9
    FCF yield3.1%
    As of Nov 17, 2026

    Historical Medians

    Against its 10-year medians, its P/S is 8.3% above 2.4x and its P/B is 25.0% above 1.6x.

    MultipleCurrent5-year median10-year median
    P/E23.2x16.8xN/A
    P/S2.6x1.6x2.4x
    P/B2.0x1.2x1.6x
    Medians of month-end values through Oct 2026: 60 months (5-year) and 98 months (10-year).

    Valuation History

    Over the 7 of the 8 year ends shown that have a P/E, its P/E ranged from 11.0x in 2022 to 65.3x in 2020.

    Year endPriceP/EP/SP/B
    2025$22.6323.8x2.4x1.7x
    2024$12.1113.3x1.3x1.0x
    2023$14.9016.7x1.7x1.2x
    2022$12.2211.0x1.4x0.8x
    2021$28.3827.0x2.9x1.8x
    2020$30.6765.3x4.2x1.8x
    2019$29.4527.8x3.5x2.0x
    2018$31.53N/A3.5x2.2x
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported; periods with losses are left out.

    GNG Valuation

    GNG viewFairly valued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About ELAN

    What is ELAN's forward P/E ratio?

    Elanco Animal Health has a forward P/E ratio of 20.6x.

    Is ELAN stock overvalued?

    GNG's valuation label for ELAN is Fairly valued. Its P/E of 23.2x compares with a median of 18.2x across 10 similar companies.

    What is ELAN's price to sales ratio?

    Elanco Animal Health has a price to sales ratio of 2.6x.

    What is Elanco Animal Health's average P/E ratio over 5 years?

    Elanco Animal Health's median P/E over the last 5 years is 16.8x, from 60 month-end values through Oct 2026.

    What is ELAN's PEG ratio?

    Elanco Animal Health has a PEG ratio of 8.9.